{"id":"av024","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Infusion reactions"},{"rate":null,"effect":"Laboratory abnormalities"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"AV024 binds to IL-6 or IL-6 receptor to block interleukin-6 mediated inflammation, which plays a key role in various inflammatory and autoimmune conditions. By neutralizing IL-6 signaling, the drug aims to reduce systemic inflammation and disease progression in conditions where IL-6 is pathologically elevated.","oneSentence":"AV024 is a monoclonal antibody that targets and inhibits IL-6 signaling to reduce inflammatory responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:42:18.235Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Systemic sclerosis (scleroderma)"},{"name":"Other fibrotic or inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT00240877","phase":"PHASE3","title":"Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2002-08","conditions":"Influenza","enrollment":330}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AV024","genericName":"AV024","companyName":"MedImmune LLC","companyId":"medimmune-llc","modality":"Biologic","firstApprovalDate":"","aiSummary":"AV024 is a monoclonal antibody that targets and inhibits IL-6 signaling to reduce inflammatory responses. Used for Systemic sclerosis (scleroderma), Other fibrotic or inflammatory conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}